JPRN-jRCT2043210005已完成1 期
Clinical study of CL2020 in patients with acute respiratory distress syndrome associated with SARS-CoV-2 infection - Clinical study of CL2020 in patients with acute respiratory distress syndrome associated with SARS-CoV-2 infection
Fukushima Tatsunobu0 个研究点目标入组 43 人开始时间: 2021年4月21日最近更新:
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- 入组人数
- 43
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 18age old 至 ot applicable（—）
- 性别
- All
入选标准
- •SARS-CoV-2 positive patients by RT-PCR
- •-Patients diagnosed with ARDS by Berlin definition
- •-Patients who are intubated and under mechanical ventilatory control
排除标准
- •-Patients managed by Extracorporeal Membrane Oxygenation (ECMO) or using ventilation techniques such as High Frequency Oscillatory Ventilation (HFOV)
- •-Patients who are not expected to survive for about 72 hours
研究者
相似试验
已完成
2 期
A clinical study of CL2020 in patients with spinal cord injuryspinal cord injuryJPRN-jRCT1080224764ife Science Institute Inc.10
已完成
不适用
A retrospective evaluation of patients with acute appendicitis who have been managed conservatively at a metropolitan health network in Melbourne, Australia from 2011 to 2016appendicitisACTRN12618000722291Eastern Health50
进行中（未招募）
1 期
Phase II Study of ADI-PEG 20 in Patients with Relapsed Sensitive or Refractory Small Cell Lung CancerRelapsed Sensitive or Refractory Small Cell Lung CancerMedDRA version: 14.1Level: PTClassification code 10041070Term: Small cell lung cancer recurrentSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2009-017885-22-BEudwig Institute for Cancer Research, Ltd42
进行中（未招募）
1 期
Phase II Study of ADI-PEG 20 in Patients with Relapsed Sensitive or Refractory Small Cell Lung CancerEUCTR2009-017885-22-DEudwig Institute for Cancer Research, Ltd22
进行中（未招募）
1 期
ADI-PEG 20 in patients with relapsed sensitive or refractory small cell lung cancerSmall Cell Lung CancerEUCTR2009-017885-22-GBudwig Institute For Cancer Research48